ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial
Regional Anesthesia & Pain Medicine · 2024-05 · 49 (5) · 346-354
DOI: 10.1136/rapm-2023-104751 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Regional Anesthesia & Pain Medicine, online erschienen am 27.08.2023. Verfasst von Nagy A Mekhail und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pain Management, Cleveland Clinic, Cleveland, Ohio, USA mekhain@ccf.org. Hauptthemen laut MEDLINE: Spinal Cord Stimulation, Chronic Pain. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Saluda Medical.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Introduction
The evidence for spinal cord stimulation (SCS) has been criticized for the absence of blinded, parallel randomized controlled trials (RCTs) and limited evaluations of the long-term effects of SCS in RCTs. The aim of this study was to determine whether evoked compound action potential (ECAP)-controlled, closed-loop SCS (CL-SCS) is associated with better outcomes when compared with fixed-output, open-loop SCS (OL-SCS) 36 months following implant.
Methods
The EVOKE study was a multicenter, participant-blinded, investigator-blinded, and outcome assessor-blinded, randomized, controlled, parallel-arm clinical trial that compared ECAP-controlled CL-SCS with fixed-output OL-SCS. Participants with chronic, intractable back and leg pain refractory to conservative therapy were enrolled between January 2017 and February 2018, with follow-up through 36 months. The primary outcome was a reduction of at least 50% in overall back and leg pain. Holistic treatment response, a composite outcome including pain intensity, physical and emotional functioning, sleep, and health-related quality of life, and objective neural activation was also assessed.
Results
At 36 months, more CL-SCS than OL-SCS participants reported ≥50% reduction (CL-SCS=77.6%, OL-SCS=49.3%; difference: 28.4%, 95% CI 12.8% to 43.9%, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pain Management, Cleveland Clinic, Cleveland, Ohio, USA mekhain@ccf.org.
- Neurosurgical Services, Anesthesia Pain Care Consultants, Boca Raton, Florida, USA.
- Spine and Nerve Center of the Virginias, West Virginia University - Health Sciences Campus, Morgantown, West Virginia, USA.
- Carolinas Pain Institute, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- Premier Pain Centers, Shrewsbury, New Jersey, USA.
- Research, Integrated Pain Management Medical Group Inc, Walnut Creek, California, USA.
ORCID-Profile: Nagy A Mekhail, Timothy R Deer, Shrif J Costandi, Jonathan M Hagedorn, Rui V Duarte
Förderung
- Saluda Medical
Zitieren
APA
Mekhail, N. A., Levy, R. M., Deer, T. R., Kapural, L., Li, S., Amirdelfan, K., Pope, J. E., Hunter, C. W., Rosen, S. M., Costandi, S. J., Falowski, S. M., Burgher, A. H., Gilmore, C. A., Qureshi, F. A., Staats, P. S., Scowcroft, J., McJunkin, T., Carlson, J., Kim, C. K., …, & EVOKE Study Group (2024). ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial. Regional Anesthesia & Pain Medicine, 49(5), 346-354. https://doi.org/10.1136/rapm-2023-104751
Vancouver
Mekhail NA, Levy RM, Deer TR, Kapural L, Li S, Amirdelfan K, et al. ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial. Regional Anesthesia & Pain Medicine. 2024;49(5):346-354. doi:10.1136/rapm-2023-104751
BibTeX
@article{Mekhail2024,
author = {Mekhail, Nagy A and Levy, Robert M and Deer, Timothy R and Kapural, Leonardo and Li, Sean and Amirdelfan, Kasra and Pope, Jason E and Hunter, Corey W and Rosen, Steven M and Costandi, Shrif J and Falowski, Steven M and Burgher, Abram H and Gilmore, Christopher A and Qureshi, Farooq A and Staats, Peter S and Scowcroft, James and McJunkin, Tory and Carlson, Jonathan and Kim, Christopher K and Yang, Michael I and Stauss, Thomas and Petersen, Erika A and Hagedorn, Jonathan M and Rauck, Richard and Kallewaard, Jan W and Baranidharan, Ganesan and Taylor, Rod S and Poree, Lawrence and Brounstein, Dan and Duarte, Rui V and Gmel, Gerrit E and Gorman, Robert and Gould, Ian and Hanson, Erin and Karantonis, Dean M and Khurram, Abeer and Leitner, Angela and Mugan, Dave and Obradovic, Milan and Ouyang, Zhonghua and Parker, John and Single, Peter and Soliday, Nicole and EVOKE Study Group, EVOKE Study Group},
title = {ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial},
journal = {Regional Anesthesia & Pain Medicine},
year = {2024},
volume = {49},
number = {5},
pages = {346--354},
doi = {10.1136/rapm-2023-104751}
}
EUVIMED